By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Biologics in Spine Surgery
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Specialties > Orthopaedics > Biologics in Spine Surgery
OrthopaedicsTechnology

Biologics in Spine Surgery

PatrickDriscoll
PatrickDriscoll
Share
2 Min Read
mHealth Patient Care
SHARE

Successful bone fusion requires three critical elements: an osteogenic potential capable of directly providing cells to the newly forming bone, osteoinductive factors that can cause osteoprogenitor stem cells to differentiate into osteoblasts, and an osteoconductive scaffold that facilitates neovascularization and supports the ingrowth of bone.

Successful bone fusion requires three critical elements: an osteogenic potential capable of directly providing cells to the newly forming bone, osteoinductive factors that can cause osteoprogenitor stem cells to differentiate into osteoblasts, and an osteoconductive scaffold that facilitates neovascularization and supports the ingrowth of bone.

While autograft has traditionally been the material of choice for spinal fusion, there has been an unacceptably high rate of pseudoarthrosis has been reported in the literature, ranging from 5-43%. This has helped to drive development of new and improved procedures and new devices intended to improve the rate of successful spinal fusion, but symptomatic pseudoarthrosis has continued to be reported at rates of 10-15%. In addition, the frequent incidence of pain at the site of the bone graft harvest has always been a serious drawback to the use of autograft for spinal fusion. Problems such as these have caused surgeons and companies to search for novel biological strategies and materials that may serve as alternatives to autograft, to stimulate strong and successful bone fusion.

[Inset: DePuy Vertigraft]

More Read

Medical Technology Financings Over $400 million in May 2011
ABA Practice Management Software Facilitates Remote Sessions
HIMSS Federal & Stage Public Policy Update
Blockchain Technology is Changing the Trajectory of the Healthcare Sector
7 Great Tips for Securing Personal Health Information

A number of companies are working in the Biologics space, not only marketing present products but also developing novel proprietary products. Among the interesting developments worth watching are new technologies for bone and disc regeneration, and advances in gene therapy and in osteoinductive proteins and carrier matrices, and mesenchymal stem cells.

See the MedMarket Diligence report #M520 for details (interim report available).

     

TAGGED:biologicsmedical technologyorthopaedicsspinal surgery
Share This Article
Facebook Copy Link Print
Share
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

uv protection in winter
Winter Sun Safety: Why UV Protection Matters Year-Round
Health
October 29, 2025
Nurse Scheduling Software
Evaluating 7 Best Nurse Scheduling Software
Nursing Technology
October 28, 2025
contamination
Batch Failures And The Hidden Costs Of Contamination
Health Infographics
October 21, 2025
Medication Management For Seniors
Simplifying Medication Management For Seniors
Infographics Senior Care
October 21, 2025

You Might also Like

Medical DevicesMedical InnovationsTechnology

5 Important Things To Expect From Medtech In 2019

January 15, 2019
OrthopaedicsSpecialties

7 Most Unnoticeable Yet Helpful Remedies for Lower Back Pain

April 9, 2020

June 6 – 9 Jefferies to Host 2011 Global Healthcare Conference

May 20, 2011

Eliminating Shades of Gray in Anatomy: 7 Personalized Healthcare Tests

March 26, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?